Legal & General Group
BNTX icon

Legal & General Group’s BioNTech BNTX Stock Holding History

Legal & General Group’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.8M Sell
320,287
-29,721
-8% -$2.8M 0.01% 751
2026
Q1 		$31M Buy
350,008
+28,897
+9% +$2.97M 0.01% 708
2025
Q4 		$30.6M Buy
321,111
+9,528
+3% +$960K 0.01% 720
2025
Q3 		$30.7M Sell
311,583
-4,165
-1% -$445K 0.01% 724
2025
Q2 		$33.6M Buy
315,748
+62,288
+25% +$6.29M 0.01% 699
2025
Q1 		$23.1M Buy
253,460
+5,959
+2% +$667K 0.01% 766
2024
Q4 		$27.9M Buy
247,501
+35,434
+17% +$4.04M 0.01% 736
2024
Q3 		$25.2M Buy
212,067
+9,136
+5% +$840K 0.01% 770
2024
Q2 		$16.3M Buy
202,931
+32,759
+19% +$2.99M ﹤0.01% 906
2024
Q1 		$15.8M Buy
170,172
+12,146
+8% +$1.16M ﹤0.01% 924
2023
Q4 		$16.6M Buy
158,026
+22,182
+16% +$2.24M 0.01% 896
2023
Q3 		$14.8M Buy
135,844
+7,390
+6% +$817K 0.01% 907
2023
Q2 		$13.9M Buy
128,454
+26,718
+26% +$3.01M ﹤0.01% 954
2023
Q1 		$12.6M Buy
101,736
+7,235
+8% +$993K ﹤0.01% 960
2022
Q4 		$14.4M Buy
94,501
+3,195
+3% +$492K 0.01% 910
2022
Q3 		$12.3M Buy
91,306
+13,656
+18% +$2.09M ﹤0.01% 946
2022
Q2 		$11.6M Buy
77,650
+17,885
+30% +$2.73M ﹤0.01% 999
2022
Q1 		$10.2M Buy
59,765
+28,493
+91% +$4.79M ﹤0.01% 1145
2021
Q4 		$7.62M Buy
31,272
+4,769
+18% +$1.31M ﹤0.01% 1352
2021
Q3 		$7.33M Buy
26,503
+8,333
+46% +$2.65M ﹤0.01% 1340
2021
Q2 		$4.06M Sell
18,170
-25,301
-58% -$4.77M ﹤0.01% 1647
2021
Q1 		$4.75M Sell
43,471
-457
-1% -$48.5K ﹤0.01% 1576
2020
Q4 		$3.58M Buy
+43,928
New +$4.31M ﹤0.01% 1639

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Legal & General Group's BNTX Position: Q2 2026 in Review

Legal & General Group reduced its BioNTech (BNTX) stake by 8.5% in Q2 2026, selling an estimated $2.8M and leaving 320,287 shares worth $29.8M. The position accounts for 0.01% of the portfolio, ranked #751.

Legal & General Group first reported a position in BNTX in Q4 2020 and has held it in 23 quarters since. The position peaked at $33.6M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Legal & General Group held 320,287 shares of BioNTech worth $29.8M as of Q2 2026.
  • Legal & General Group sold 29,721 BioNTech shares in Q2 2026, an estimated $2.8M.
  • BioNTech made up 0.01% of Legal & General Group's portfolio in Q2 2026, its #751 holding.
  • Legal & General Group first reported a position in BioNTech in Q4 2020 and has held it in 23 quarters since.
  • Legal & General Group's BioNTech position peaked at $33.6M in Q2 2025.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.